跳至主要内容
临床试验/CTRI/2020/07/026671
CTRI/2020/07/026671尚未招募未知

A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment

Bisleri charitable trust0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients confirmed to be COVID-19 positive by quantitative real time polymerase chain reaction (QRT-PCR) assay
  • 2. Patients that meet any one of the criteria of moderate stage
  • 3. Patients who give written informed consent.
  • 4. Age 18 â?? 65 years

排除标准

  • 1. Mild or severe stage
  • 2. G6PD deficiency
  • 3. Hyperthyroidism
  • 4. Bleeding disorders (any coagulopathies)
  • 5. Chronic uncontrolled illnesses such as uncontrolled diabetes, uncontrolled hypertension chronic renal failure, chronic liver disease, chronic neurodegenerative disorders, chronic heart conditions (chronic heart failure, chronic angina, previous
  • myocardial infarction), malignancies, etc.,
  • 6. Pregnant and lactating women
  • 7. Patients on immunosuppressant drugs
  • 8. Patients with a history of organ transplantation
  • 9. Patients who are participating in other clinical trials

研究者

发起方
Bisleri charitable trust

相似试验

尚未招募
不适用
A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19)COVID-19
ITMCTR2000003144Guangzhou Eighth People's Hospital
进行中(未招募)
Unknown
HS COVID-related post-traumatic stress disorder (PTSD) experimental treatment trialPost-Traumatic Stress Disorder (PTSD)Mental and Behavioural Disorders
ISRCTN52834682King's College London18
进行中(未招募)
1 期
Treatments of COVID-19 in primary care in the NetherlandsPatients with symptomatic COVID-19 in the community and in primary care, who are at higher risk of a complicated illness course.MedDRA version: 23.0Level: PTClassification code: 10084268Term: COVID-19 Class: 100000004862
CTIS2022-501559-99-00Maastricht University682
尚未招募
不适用
Precalence study on ICU Treatment of COVID-19 patients in Northern and Western Saxony in the first half of 2020 - PraeCoSaJ12.8J80.09Other viral pneumonia
DRKS00021705Klinik für Anästhesiologie und IntensivtherapieUniversitätsklinikum Leipzig100
招募中
Unknown
Prospective observational study of COVID-19 patients in the TOKUSHUKAI GROUPThe purpose of this study is to collect information of the clinical course of patients with COVID-19 treated at Tokushukai hospitals with and without antiviral drugs and to explore the clinical course in the acute phase, the frequency of severe disease, and frequency of post COVID-19 condition by the treatment, after adjusting by patient background including risk factor(s) and symptoms at the time of registration.
JPRN-UMIN000053506Shionogi & Co., Ltd.30,000
Ozone Therapy for Covid 19 patients | 临床试验